Study reveals SARS-CoV-2 can infect dopamine neurons causing senescence
Dopamine neuron senescence is a hallmark of Parkinson’s disease
Read Moreby Jen Brogan | Feb 2, 2024 | News | 0
Dopamine neuron senescence is a hallmark of Parkinson’s disease
Read Moreby John Pinching | Sep 13, 2022 | News | 0
Modelling indicates a 307% increase in cases identified between 2020 and 2021
Read Moreby John Pinching | Apr 28, 2022 | News | 0
Women, those who are obese and those on mechanical ventilation are all more likely to suffer from the effects long-term COVID-19
Read Moreby Lucy Parsons | Aug 4, 2021 | News | 0
Less than one in 20 children had symptoms for more than four weeks
Read Moreby Lucy Parsons | Jun 25, 2021 | News | 0
Study of self-reported data found a sizeable portion of individuals reporting persistent COVID-19 symptoms
Read Moreby Lucy Parsons | Feb 18, 2021 | News | 0
Funding will be given to four long COVID research studies
Read Moreby Lucy Parsons | Dec 18, 2020 | News | 0
Specialist help will be available at 69 sites across the country
Read Moreby Lucy Parsons | Dec 4, 2020 | News | 0
LYT-100 will be evaluated in patients with persistent symptoms caused by COVID-19
Read Moreby Lucy Parsons | Dec 1, 2020 | News | 0
Research conducted at Oxford University used new scanning method
Read Moreby Selina McKee | Nov 16, 2020 | News | 0
It is hoped that the move will help to tackle the persistent symptoms – such as fatigue and brain fog – suffered by people who have developed the condition
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479